• 1
    Ciuna A, Andretta M, Corbari L et al. Are we going to increase the use of antidepressants up to that of benzodiazepines? Eur. J. Clin. Pharmacol. 2004; 60: 629634.
  • 2
    Isacsson G, Boethius G, Henriksson S, Jones JK, Bergman U. Selective serotonin reuptake inhibitors have broadened the utilization of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J. Affect. Disord. 1999; 53: 1522.
  • 3
    Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA. Antidepressant prescribing practices of outpatient psychiatrist. Arch. Gen. Psychiatry 1998; 55: 310316.
  • 4
    American Psychiatric Association. Practice guidelines for the treatment of psychiatric disorders. Compendium 2004; 2: 411481.
  • 5
    Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. J. Affect. Disord. 2000; 58: 1936.
  • 6
    MacGillivray S, Arroll B, Hatcher S et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: Systematic review and meta-analysis. BMJ 2003; 326: 10141017.
  • 7
    Hamels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981–2000. Ann. Pharmacother. 2002; 36: 13751379.
  • 8
    Rosholm JU, Gram LF, Isacsson G, Hallas J, Bergman U. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: A prescription database study. Eur. J. Clin. Pharmacol. 1997; 52: 205209.
  • 9
    Hansen DG, Sondergaard J, Vach W, Gram LF, Rosholm JU, Kragstrup J. Antidepressant drug use in general practice: Inter-practice variation and association with practice characteristics. Eur. J. Clin. Pharmacol. 2003; 59: 143149.
  • 10
    Hamed A, Lee A, Ren XS et al. Use of antidepressant medications: Are there differences in psychiatric visits among patient treatments in the veterans administration? Med. Care 2004; 42: 551559.
  • 11
    Chong MY, Tan CH, Fujii S et al. Antipsychotic drug prescription for schizophrenia in East Asia: Rationale for change. Psychiatry Clin. Neurosci. 2004; 58: 6167.
  • 12
    Sim K, Su A, Fujii S et al. Antipsychotic polypharmacy in patients with schizophrenia: A multicentre comparative study in East Asia. Br. J. Clin. Pharmacol. 2004; 58: 178183.
  • 13
    Hansen DG, Vach W, Rosholm JU, Sondergaard J, Gram LF, Kragstrup J. Early discontinuation of antidepressants in general practice: Association with patient and prescriber characteristics. Fam. Pract. 2004; 21: 613619.
  • 14
    WHO Collaborating Center for Drug Statistics Methodology. ATC Index with DDDs. WHO Collaborating Center for Drug Statistics Methodology, Oslo, 2003.
  • 15
    Sugahara H, Tokunaga S, Kondo T et al. Comparative adherence to antidepressant drugs in a non-psychiatric outpatient clinic setting in Japan. Prim. Care Community Psychiatry 2005; 10: 5762.
  • 16
    Oshima A, Higuchi T, Fujiwara Y et al. Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders. Psychiatry Clin. Neurosci. 1999; 53: S67S72.
  • 17
    Simon GE, Fleck M, Lucas R, Bushnell DM; LIDO Group. Prevalence and predictors of depression treatment in an international primary care study. Am. J. Psychiatry 2004; 161: 16261634.
  • 18
    De Las Cuevas C, Sanz EJ, De La Fuente JA. Variations in antidepressant prescribing practice: Clinical need or market influences? Pharmacoepidemiol. Drug Saf. 2002; 11: 515522.
  • 19
    DeVane CL. Differential pharmacology of newer antidepressants. J. Clin. Psychiatry 1998; 59: 8593.
  • 20
    Zimmerman M, Posternak M, Friedman M et al. Which factors influence psychiatrists' selection of antidepressants? Am. J. Psychiatry 2004; 161: 12851289.